Volume 15, Number 5—May 2009
Research
Seroprevalence of Antibodies to Avian Influenza Virus A (H5N1) among Residents of Villages with Human Cases, Thailand, 20051
Table 1
Characteristic | Random sample (n = 131), no. (%) | Convenience sample (n = 770), no. (%) | p value | Total sample (N = 901), no. (%) |
---|---|---|---|---|
Age group, y | 0.30 | |||
1–14 | 19 (14.5) | 178 (23.1) | 197 (21.9) | |
15–29 | 14 (10.7) | 99 (12.9) | 113 (12.5) | |
30–44 | 37 (28.2) | 177 (23.0) | 214 (23.8) | |
45–59 | 32 (24.4) | 175 (22.7) | 207 (22.9) | |
60–74 | 24 (18.3) | 109 (14.2) | 133 (14.8) | |
75–89 | 4 (3.1) | 28 (3.6) | 32 (3.6) | |
90–104 |
1 (0.8) |
4 (0.5) |
5 (0.5) |
|
Occupation | 0.04 | |||
Plant farmer | 59 (45.0) | 236 (30.6) | 295 (32.7) | |
Animal farmer | 3 (2.3) | 11 (1.4) | 14 (1.6) | |
Farmer (plant and animal) | 2 (1.5) | 7 (1.0) | 9 (0.10) | |
Merchant | 2 (1.5) | 13 (1.7) | 15 (1.7) | |
Government officer | 0 | 3 (0.4) | 3 (0.4) | |
Other (employee, housekeeper) | 42 (32.1) | 346 (44.9) | 388 (43.0) | |
Missing |
23 (17.6) |
154 (20.0) |
177 (19.6) |
|
Sex | 0.70 | |||
Male | 58 (44.3) | 324 (42.1) | 382 (42.4) | |
Female |
73 (55.7) |
446 (57.9) |
519 (57.6) |
|
Risk factors | 0.60 | |||
Direct or close contact with backyard poultry (including chickens) | 89 (67.9) | 525 (68.2) | 614 (68.1) | |
Direct or close contact with backyard chickens | 86 (65.6) | 519 (67.4) | 605 (67.1) | |
Direct or close contact with dead/sick chicken | 36 (27.5) | 196 (25.5) | 232 (25.7) | |
Close contact with a person with a confirmed case
of avian influenza A |
13 (9.9) |
51 (6.6) |
64 (7.1) |
|
Acute respiratory symptoms* | 0.31 | |||
Symptoms | 12 (9.2) | 98 (12.7) | 110 (12.2) | |
No symptoms |
119 (90.8) |
672 (87.3) |
791 (87.89) |
|
Influenza-like illness† | 0.39 | |||
Symptoms | 7 (5.3) | 61 (7.9) | 68 (7.5) | |
No symptoms | 124 (94.7) | 709 (92.1) | 833 (92.5) |
*Acute respiratory symptoms were rhinorrhea, cough, sore throat, or dyspnea.
†Influenza-like illness was defined as a temperature >38.0°C in conjunction with any of the following: rhinorrhea, cough, sore throat, or dyspnea.
1Preliminary findings from this study were presented on June 18, 2007, at the Options for the Control of Influenza Conference VI, Toronto, Ontario, Canada.
Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.